AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME

AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME was reported 59 times

AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human C1 Esterase Inhibitor [EPC] 2 0.0005
1 Plasma Kallikrein Inhibitor [EPC] 1 0.0004
2 Human Immunoglobulin G [EPC] 3 0.0001
3 Provitamin D2 Compound [EPC] 3 0.0001
4 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
5 CD30-directed Immunoconjugate [EPC] 1 0.0001
6 Alkylating Drug [EPC] 23 0.0001
7 CD20-directed Cytolytic Antibody [EPC] 28 0.0001
8 Bile Acid Sequestrant [EPC] 1 0.0001
9 Alkaloid [EPC] 2 0.0001
10 Nucleoside Metabolic Inhibitor [EPC] 19 0.0001
11 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
12 Interleukin-1 Receptor Antagonist [EPC] 1 0.0001
13 Bile Acid [EPC] 1 0.0000
14 Aluminum Complex [EPC] 1 0.0000
15 Calcineurin Inhibitor Immunosuppressant [EPC] 4 0.0000
16 Interleukin-17A Antagonist [EPC] 1 0.0000
17 Catecholamine [EPC] 2 0.0000
18 Corticosteroid [EPC] 31 0.0000
19 Muscle Relaxant [EPC] 1 0.0000
20 Epidermal Growth Factor Receptor Antagonist [EPC] 1 0.0000
21 Folate Analog Metabolic Inhibitor [EPC] 7 0.0000
22 Fluoroquinolone Antibacterial [EPC] 2 0.0000
23 Serotonin-3 Receptor Antagonist [EPC] 2 0.0000
24 HER2/neu Receptor Antagonist [EPC] 1 0.0000
25 Topoisomerase Inhibitor [EPC] 1 0.0000
26 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
27 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
28 Selective T Cell Costimulation Modulator [EPC] 1 0.0000
29 Osmotic Laxative [EPC] 2 0.0000
30 Vascular Endothelial Growth Factor Inhibitor [EPC] 1 0.0000
31 Tumor Necrosis Factor Blocker [EPC] 5 0.0000
32 Platinum-based Drug [EPC] 1 0.0000
33 Factor Xa Inhibitor [EPC] 1 0.0000
34 Kinase Inhibitor [EPC] 2 0.0000
35 Proton Pump Inhibitor [EPC] 1 0.0000